do-me/EUR-LEX huggingface dataset:
Prior notification of a concentration (Case M.7468 — Oji Holdings/Itochu Corporation/Sales and Production JVs) — Candidate case for simplified procedure  Text with EEA relevance
Date: 2014-12-05
Institutions: European Commission
Subjects: Japan, economic concentration, electrical energy, energy industry, merger control, pulp and paper industry








C_2014436EN.01000901.xml










5.12.2014   


EN


Official Journal of the European Union


C 436/9





Prior notification of a concentration
(Case M.7468 — Oji Holdings/Itochu Corporation/Sales and Production JVs)
Candidate case for simplified procedure
(Text with EEA relevance)
(2014/C 436/06)






1.


On 27 November 2014, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings Itochu Enex Co., Ltd (‘Itochu Enex’ of Japan) and Oji Green Resources Co., Ltd (‘Oji Green’ of Japan) acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of a sales and a production joint ventures by way of purchase of shares in two newly created companies constituting joint ventures.










2.


The business activities of the undertakings concerned are:
—   for Itochu Enex: sales of energy related products such as petroleum products, LP gas and other types of gas, electric power as well as vehicle-related products and services,
—   for Oji Green: sales of pulp and wood products, plantation and energy business,
—   for the production and sales joint ventures: production and retail supply of electricity in Japan.










3.


On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in this Notice.










4.


The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.7468 — Oji Holdings/Itochu Corporation/Sales and Production JVs, to the following address:





European Commission




Directorate-General for Competition




Merger Registry




1049 Bruxelles/Brussel




BELGIQUE/BELGIË










(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2)  OJ C 366, 14.12.2013, p. 5.
Case T-652/14 R: Order of the President of the General Court of 5 December 2014  — AF Steelcase v OHIM (Interim measures — Public procurement — Supply and installation of furniture — Rejection of a submitted tender — Application for suspension of operation — No prima facie case)
Date: 2014-12-05
Institutions: General Court
Subjects: furniture industry, invitation to tender, refusal to bid, supplies contract








C_2015056EN.01002401.xml










16.2.2015   


EN


Official Journal of the European Union


C 56/24





Order of the President of the General Court of 5 December 2014 — AF Steelcase v OHIM
(Case T-652/14 R)
((Interim measures - Public procurement - Supply and installation of furniture - Rejection of a submitted tender - Application for suspension of operation - No prima facie case))
(2015/C 056/34)
Language of the case: Spanish

Parties


Applicant: AF Steelcase, SA (Madrid, Spain) (represented by: S. Rodríguez Bajón, lawyer)

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) (represented by: N. Bambara and M. Paolacci, acting as Agents)

Re:

Application for interim measures seeking, essentially, suspension of the decision of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) of 8 July 2014 rejecting the tender submitted by the applicant in the context of the tender procedure concerning the supply and installation of furniture and accessories in OHIM’s buildings.

Operative part of the order







1.


The application for interim measures is dismissed.










2.


The costs are reserved.
Case T-798/14: Action brought on 5 December 2014 — DenizBank v Council
Date: 2014-12-05
Institutions: General Court
Subjects: economic sanctions, equal treatment, fundamental rights, international sanctions, principle of proportionality, rights of the defence








C_2015089EN.01002901.xml










16.3.2015   


EN


Official Journal of the European Union


C 89/29





Action brought on 5 December 2014 — DenizBank v Council
(Case T-798/14)
(2015/C 089/35)
Language of the case: English

Parties


Applicant: DenizBank A.Ș. (Esentepe, Turkey) (represented by: M. Lester and O. Jones, Barristers, R. Mattick and S. Utku, Solicitors)

Defendant: Council of the European Union

Form of order sought

The applicant claims that the Court should:






—


annul Council Decision 2014/659/CFSP of 8 September 2014 (1) and Council Regulation (EU) No 960/2014 of 8 September 2014 (2) (together the contested measures) insofar as they apply to the applicant;










—


declare the inapplicability pursuant to Article 277 TFEU as regards Article 1 of the 8 September Decision, and Article 1(5) of the 8 September Regulation; and










—


order the Council to pay the costs.





Pleas in law and main arguments

In support of the action, the applicant relies on four pleas in law.






1.


First plea in law, alleging that the Council has breached its duty to give reasons for imposing the contested measures on the applicant. Further, the applicant contends that the Council has given it no reasons at all for imposing the contested measures on it, nor even informed it of its inclusion.










2.


Second plea in law, alleging that the Council has failed to safeguard the applicant’s rights of defence, including its right to a fair hearing and to effective judicial review. The applicant submits that the Council has given the applicant no reasons or evidence for imposing the contested measures on it, no opportunity for it to comment on the case against it, and has thereby also impeded the Court from ‘exercising effective judicial review’.










3.


Third plea in law, alleging that insofar as it has imposed the contested measures on the applicant, the Council has breached the Ankara Agreement between Turkey and the EU (and its Additional Protocol) in a number of respects.










4.


Fourth plea in law, alleging that the Council has breached the principles of non-discrimination and proportionality, and has imposed an unjustified and disproportionate restriction on the applicant’s fundamental rights.






(1)  Council Decision 2014/659/CFSP of 8 September 2014 amending Decision 2014/512/CFSP concerning restrictive measures in view of Russia's actions destabilising the situation in Ukraine (OJ L 271, p. 54).

(2)  Council Regulation (EU) No 960/2014 of 8 September 2014 amending Regulation (EU) No 833/2014 concerning restrictive measures in view of Russia's actions destabilising the situation in Ukraine (OJ L 271, p. 3).
Prior notification of a concentration (Case M.7275 — Novartis/GlaxoSmithKline oncology business)  Text with EEA relevance
Date: 2014-12-05
Institutions: European Commission
Subjects: economic concentration, medical research, merger control, pharmaceutical industry








C_2014436EN.01001101.xml










5.12.2014   


EN


Official Journal of the European Union


C 436/11





Prior notification of a concentration
(Case M.7275 — Novartis/GlaxoSmithKline oncology business)
(Text with EEA relevance)
(2014/C 436/08)






1.


On 28 November 2014, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which Novartis AG (‘Novartis’, Switzerland) acquires the business relating to a portfolio of oncology products excluding manufacturing (the ‘Target’) from GlaxoSmithKline plc. (‘GSK’, United Kingdom), by way of purchase of assets.










2.


The proposed concentration forms part of a three-part inter-conditional transaction whereby GSK has agreed to acquire sole control over Novartis' vaccine business (excluding the influenza business) and GSK and Novartis have agreed to combine their consumer health businesses into a new venture. These parts of the overall transaction have been notified on 28 November 2014 as case M.7276.










3.


The business activities of the undertakings concerned are:






—


Novartis is a Swiss healthcare company, active in five broad areas of healthcare: pharmaceuticals, eye care, generics, Over-the-Counter (‘OTC’) and vaccine products,










—


the Target is active globally in the research, development, and marketing of oncology products for various indications.














4.


On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.










5.


The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.7275 — Novartis/GlaxoSmithKline oncology business, to the following address:





European Commission




Directorate-General for Competition




Merger Registry




1049 Bruxelles/Brussel




BELGIQUE/BELGIË










(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).